Login

Clinical Trials for Special Populations - Dr. Robert Jacobson, a Professor of Pediatric and Adolescent Medicine 00:00:00

Share On Facebook Share On Twitter

Clinical Trials for Special Populations

Recent Videos

00:10:00
How LRT Capital's Lucas Krupinski Combines Economic Moats and Quant Discipline for Long-Term Outperformance|Mr. Tomicki,CEO,LRT Capital
00:10:00
AlphaBot Revolutionizes Alternative Investment Research with 10x Efficiency and Seamless Multi-Asset Integration at a Fraction of the Cost|Dmitri Alexeev,CIO,Man Group
00:10:00
Harcourt’s Strategy-Focused Fund of Hedge Funds Outperforms with Precision Manager Selection and Unmatched Fee Efficiency|Ilario Scasascia,ED,Vontobel Asset Management AG
00:10:00
Defying Convention with a Systematic Market Timing Strategy That Thrives in Volatility|Heeten H. Doshi,Founder,Doshi Capital
00:10:00
 Exploiting market inefficiencies in undervalued and overlooked African markets|André Steyn,CEO,Steyn Capital
00:10:00
Europe’s Independent Hedge Fund Powerhouse with a Disciplined Edge and Global Reach|Dr Werner Goricki ,CIO,Prime Capital
00:10:00
A Quantitative Edge in China A-Shares and Global Access via Hong Kong|Bo Huang,President,Jasper Capital
00:10:00
Uncorrelated Returns, Predictable Yields: How Laureola’s Life Settlement Strategy Offers Stability and Alpha in Volatile Markets| Tony Bremness,CFA,Laureola Advisors
00:10:00
Why 2022 Marked the Greatest Asset Raising Environment in Hedge Fund History—and How Managers Can Win Big at Cap Intro Events|Don Steinbrugge,CEO,Agecroft Partners
00:10:00
John Katzman Urges EdTech Industry to Rethink Assumptions, Use Data for Support—Not Surveillance|John Katzman, Ceo, Noodle
00:10:00
Pioneering ESG-Driven Alpha Through Data, Discipline, and Sustainable Development Themes|Larry Abele ,CEO,Auriel Capital Management LLP
00:10:00
Mastering Volatility and Skew to Deliver Rare Alpha in Crowded, Convex Markets|Nigol Koulajian,CIO,AlphaQuest
00:10:00
Blending Quantitative Precision and Trading Experience to Navigate Japan’s Markets with Systematic Edge|Aman Oberoi,CEO,K2Q Capital
00:10:00
Contrarian UK Equity Specialists Unlocking Asymmetric Value in a Post-Brexit Market|Alyx Wood,CIO,Kernow Asset Management
00:10:00
Revolutionizing Art Investment Through Technology, Transparency, and Blue-Chip Access|Tony Dalwood,CEO,Gresham House Ventures
00:10:00
Empowering Global Investment Managers with Infrastructure, Compliance, and Expertise|Clayton Heijman,CEO,Privium Fund Management

Suggestions

00:10:00
Real Estate Investment Trust Emira Property Fund's CEO Discusses Operational Resilience Amid Power Challenges and Strategic Growth Initiatives in South Africa | Geoffrey Michael Jennett, CEO, Emira Property Fund.
00:10:00
Generous Sponsorship by White Oaks Wealth Advisors | Sharon Bloodworth - CEO of White Oaks Wealth Advisors, Inc.
00:10:00
Evaluating the Risk Dynamics of High-Risk Mutual Fund Categories | Nimesh Shah, CEO , ICICI Prudential Mutual Fund .
00:10:00
Exploring Innovations in Cancer Immunotherapy|Søren Bregenholt, CEO, Alligator Bioscience AB.
00:10:00
Unlocking Creativity: DMG Mori Harnesses Creo and Windchill Power | Alfred Geißler - CEO of DMG Mori AG
00:10:00
The Relationship Between CDS, Bonds, and Equity Pricing
00:10:00
Unbound Group PLC CEO Ian Watson Discusses Growth Plans and Market Debut | Ian Watson, CEO, Unbound Group PLC.
00:10:00
Financial Pulse: April 2022 Market Update and Tax Season Insights with Michael McCarthy | Michael McCarthy, President, Financial Consulate Inc.
00:10:00
Improving health and well-being in our community|Robert G. Riney,President and CEO,Henry Ford Hospital
00:10:00
Interview with Oliver Hassler, Chairman and CEO of Pix Resources: Strategic Growth and Sustainability in Mineral Sands
00:10:00
Base Resources: An Overview of Operations and Future Prospects
00:10:00
CEO Paul Goranson at 2024 Energy Transition Metals Summit in DC | Paul Goranson - CEO of enCore Energy Corp

© 2017 - Neuhu+